IFNG and neoplasm: Because many immune-based therapies are designed to accentuate the CD8+ T cell immune response and augment IFN-γ production in the tumor microenvironment, understanding this unique and paradoxical mechanism of immunoregulation is critical for the rational design of therapeutic strategies specific for lung cancer.